GTx (Fareston) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
GTx (Fareston) General Information
Description
US commercial rights of Fareston. It consist of rights to market, distribute and sell Fareston in the United States. Fareston is a pharmaceutical drug for the treatment of metastatic breast cancer in postmenopausal women.
Contact Information
Corporate Office
- 175 Toyota Plaza
- 7th Floor
- Memphis, TN 38103
- United States
Corporate Office
- 175 Toyota Plaza
- 7th Floor
- Memphis, TN 38103
- United States
GTx (Fareston) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GTx (Fareston) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
GTx (Fareston) FAQs
-
Where is GTx (Fareston) headquartered?
GTx (Fareston) is headquartered in Memphis, TN.
-
What industry is GTx (Fareston) in?
GTx (Fareston)’s primary industry is Buildings and Property.
-
Is GTx (Fareston) a private or public company?
GTx (Fareston) is a Private company.
-
What is the current valuation of GTx (Fareston)?
The current valuation of GTx (Fareston) is .
-
What is GTx (Fareston)’s current revenue?
The current revenue for GTx (Fareston) is .
-
Who are GTx (Fareston)’s investors?
GTx (Pharmaceuticals) has invested in GTx (Fareston).
-
When was GTx (Fareston) acquired?
GTx (Fareston) was acquired on 01-Oct-2012.
-
Who acquired GTx (Fareston)?
GTx (Fareston) was acquired by Kyowa Kirin International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process